Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome

NCT05145348 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05145348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05145348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
February 3, 2021
Completion date
June 30, 2023
Enrollment
640 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome, sars-cov-2 vaccination